$ENVI News
Last published 4y ago
- 4y agoENVIGreenLight Biosciences begins trading today as Nasdaq: GRNA on the closing of its business combination with Environmental Impact Acquisition Corp.PR NewswireBOSTON, Feb. 3, 2022 /PRNewswire/ -- GreenLight Biosciences ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp
- 4y agoENVIEnvironmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022PR NewswireBOSTON, Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ:ENVI), a publicly-traded special purpose acquisition company, announced today that its business combination with Greenlight Biosciences was approved in a shareholde
- 4y agoENVIGreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control PestsPR NewswireBOSTON, Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA as a seed
- 4y agoENVIENVI Announces Quorum to Pass Business Combination With GreenLight Biosciences and Achievement of All Transaction Requirements Following the Redemption DeadlinePR NewswireBOSTON, Jan. 28, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation ("ENVI" or the "Company") (NASDAQ:ENVI) today announced that it had achieved a quorum for the special meeting of its shareholders to be held on February 1, 2022 (the "Spe
- 4y agoENVIENVI and GreenLight Biosciences Announce Filing of Definitive Proxy Statement/Prospectus and the February 1st, 2022 Special Meeting to Approve Proposed Business CombinationPR NewswireBOSTON, Jan. 14, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ:ENVI) ("ENVI"), a publicly-traded special purpose acquisition company, announced today that ENVI's definitive proxy statement/prospectus (the "Proxy Statement") re
- 4y agoENVIGreenLight Biosciences expands RTP footprint for the next generation of agricultural productsPR NewswireBOSTON, Jan. 7, 2022 /PRNewswire/ -- GreenLight Biosciences, a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced the expansion of its research and development operations in Rese
- 4y agoENVIGreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidatePR NewswireBOSTON and NEW YORK, Dec. 3, 2021 /PRNewswire/ -- GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization, today announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron variant.
- 4y agoENVIGreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in AfricaPR NewswireNEW YORK, Nov. 30, 2021 /PRNewswire/ -- GreenLight Biosciences has partnered with the non-profit scientific research organization IAVI to work together on a Phase I clinical trial in Africa. IAVI and its partners were among the first to conduct HIV vacci
- 4y agoENVIGreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine ManufacturingPR NewswireBOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (NASDAQ:ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmenta
- 4y agoENVISerum Life Sciences invests in RNA biotech GreenLight by joining expanded financing for Environmental Impact Acquisition Corp.PR NewswireBOSTON, Nov. 23, 2021 /PRNewswire/ -- GreenLight Biosciences Inc., an RNA-focused biotech ("GreenLight"), and Environmental Impact Acquisition Corp. (NASDAQ:ENVI) today announced an expansion of its PIPE financing to an aggregate $124 million in gross p
- 5y agoCCIVENVIGHVISNII+1Trinity Capital Inc. Reports Third Quarter 2021 Financial ResultsPR NewswirePHOENIX, Nov. 4, 2021 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity Capital" or the "Company"), a leading specialty lending company that provides debt, including loans and equipment financing, to growth stage companies backed by technolo
- 5y agoENVIGreenlight Biosciences (ENVI) Adds Two World-Renowned Scientists To Its Scientific Advisory BoardPR NewswireBOSTON, Nov. 4, 2021 /PRNewswire/ -- GreenLight Biosciences is delighted to announce the appointment of Professor Diane E. Griffin, MD, PhD, and Emmanuel Hanon, DVM, PhD, to its Human Health Scientific Advisory Board.
- 5y agoENVIGreenlight Biosciences (ENVI) Science Day Updates Investors On Progress Across Human, Plant And Animal HealthPR NewswireBOSTON, Oct. 19, 2021 Today GreenLight Biosciences (ENVI) will hold Science Day to update investors on the company's progress towards solving some of the world's largest and most difficult problems by delivering on the full potential of RNA. "Today we
- 5y agoENVIGreenLight Biosciences opens RNA production facility for the next generation of agricultural productsPR NewswireROCHESTER, N.Y., Sept. 22, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the opening of its manufacturing plant in Rochester,
- 5y agoENVIGreenLight Biosciences Announces the Appointment of Jennifer Raymond As SVP, CMC and ManufacturingPR NewswireBOSTON, Sept. 16, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the appointment of Jennifer Raymond as SVP, CMC & Manufacturing
- 5y agoENVIEUSGGNOGMCMJMoore Kuehn Encourages GNOG, MCMJ, ENVI, and EUSG Investors to Contact Law FirmGlobeNewswireNEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair t
- 5y agoENVIGreenLight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp. to Become Publicly Traded Company, Allowing It to Better Harness Its Breakthrough Platform to Develop and Produce RNA for Human Therapies and AgricultureBusiness WireGreenLight Biosciences, Inc. to become publicly listed through business combination with Environmental Impact Acquisition Corp. (NASDAQ:ENVI) Transaction advances development of breakthrough biomanufacturing platform capable of discovering, develo
- 5y agoENVIEnvironmental Impact Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and WarrantsGlobeNewswireNew York, NY , March 03, 2021 (GLOBE NEWSWIRE) -- Environmental Impact Acquisition Corp. (the “Company”) announced today that, commencing March 8, 2021, holders of the 20,700,000 units sold in the...
- 5y agoENVIEnvironmental Impact Acquisition Corp. Announces Closing of Upsized Initial Public OfferingGlobeNewswireNEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Environmental Impact Acquisition Corp. (the “Company”), a newly organized blank check company formed for the purpose of effecting a merger, capital stock...
- 5y agoENVIEnvironmental Impact Acquisition Corp. Announces Pricing of Upsized $180 Million Initial Public OfferingGlobeNewswireNEW YORK, NY, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Environmental Impact Acquisition Corp. (the “Company”), a special purpose acquisition company sponsored by CG Investments Inc. VI, an affiliate of...